1. Stocks
    2. /
  2. Race Oncology Limited (ASX: RAC)
    3. /

Race Oncology Limited (ASX: RAC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Race Oncology Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Race Oncology Limited (ASX: RAC)
    Latest News

    A group of people in a corporate setting do a collective high five.
    Earnings Results

    Race Oncology share price leaps 5% on quarter of 'major advances'

    | Mitchell Lawler

    Quarter dominated by promising results have investors revved up...

    Read more »

    Five healthcare workers standing together and smiling.
    Healthcare Shares

    Up 38% in a month, what's sparking the recent Race Oncology share price run-up?

    | Aaron Teboneras

    What a month it has been for Race Oncology shareholders.

    Read more »

    A man in a wheelchair stretches both arms into the air in success.
    Index investing

    ASX 200 healthcare shares provided some pain relief today. Here's why

    | Aaron Teboneras

    The healthcare sector ended Thursday as the best performer on the ASX.

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    Why is the Race Oncology share price soaring 13% today?

    | Monica O'Shea

    New trial results have excited ASX investors.

    Read more »

    Boy in business suit smiles with arms crossed and rockets attached to his back representing the rocketing BrainChip share price
    Healthcare Shares

    Why did the Race Oncology share price rocket 10% today?

    | Aaron Teboneras

    Investors view Race Oncology's latest release in a positive light.

    Read more »

    A man wearing a white coat holds his hands up and mouth open with joy.
    Healthcare Shares

    Race Oncology share price soars 16% on buyback news

    | Aaron Teboneras

    The pharmaceutical company's shares are receiving a welcome boost today.

    Read more »

    Female doctor with a mask holds out hand in a stop gesture.
    Healthcare Shares

    Why is the Race Oncology share price in a trading halt?

    | Aaron Teboneras

    Race Oncology is set to release some trial results to the market in the coming days.

    Read more »

    A woman looks distressed as she stares dramatically at her phone
    Share Market News

    5 ASX shares making unbelievable news this week

    | Tristan Harrison

    These five ASX shares made headlines this week.

    Read more »

    Female scientist working in a laboratory.
    Healthcare Shares

    'Compelling results': Here's why the Race Oncology (ASX:RAC) share price is rocketing 5%

    | Zach Bristow

    The biotech company is on the share price racetrack again today – and leading its ASX peers.

    Read more »

    Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
    Share Gainers

    Why did Race Oncology (ASX:RAC) shares bounce 14% higher on Wednesday?

    | Zach Bristow

    We analyse what's underlying the gains that were made today.

    Read more »

    A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
    Healthcare Shares

    Why did the Race Oncology (ASX:RAC) share price drop 10% today?

    | Sebastian Bowen

    What happened with Race shares today?

    Read more »

    Lab technician analyses a sample in a laboratory for a clinical trial
    Healthcare Shares

    Race Oncology (ASX:RAC) share price rises following preclinical discovery

    | Alice de Bruin

    Shares in the oncology provider are up following an exciting discovery...

    Read more »

    Frequently Asked Questions

    No, Race Oncology does not pay dividends at this time.

    Sydney-headquartered Race Oncology Ltd listed on the ASX on 13 July 2016.

    RAC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Race Oncology Limited

    Race Oncology Ltd (ASX: RAC) is a clinical-stage global biotechnology company focused on cancer care.

    Race’s lead asset, bisantrene, is a small-molecule anthracene chemotherapeutic. It has demonstrated anti-cancer and cardio-protection effects in 46 clinical trials and around 70 peer-reviewed publications.

    The company is now taking its next-generation bisantrene to new fields of cancer treatment. It is initially focusing on two areas of unmet need: metastatic breast cancer (lead indication) and acute myeloid leukaemia (AML).

    As part of its business strategy and clinical program, Race is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway. This follows independent research describing bisantrene as the most potent inhibitor of fat mass and obesity-associated protein (FTO). Dysregulation of RNA (or the over-expression of FTO) has been shown to be a driver of a diverse range of cancers. Race and its partners are now in pre-clinical studies to explore the synergies and impact of bisantrene on FTO regulation.

    Profile

    since

    Note